Insulin resistance is associated with specific gut microbiota in appendix samples from morbidly obese patients

American Journal of Translational Research

Volumn 8, Issue 12, 2016, Pages 5672-5684

  Moreno Indias, Isabel ^a,b   Sánchez Alcoholado, Lidia ^a   García Fuentes, Eduardo ^b,c   Cardona, Fernando ^a,b   Queipo Ortuño, Maria Isabel ^a,b   Tinahones, Francisco J ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

Adipose tissue; Appendix; Gut integrity; Inflammation; Insulin resistance; Microbiota

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CD11B ANTIGEN; CHOLESTEROL; COMPLEMENT COMPONENT C3 RECEPTOR; GAMMA GLUTAMYLTRANSFERASE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RNA 16S; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR;

ADULT; APPENDIX; ARTICLE; ASSESSMENT OF HUMANS; BARIATRIC SURGERY; BIOCHEMICAL ANALYSIS; BIOINFORMATICS; BODY MASS; CONTROLLED STUDY; DYSBIOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTRIC BYPASS SURGERY; GENE EXPRESSION; HOMOEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; HUMAN TISSUE; INFLAMMATION; INSULIN RESISTANCE; INTESTINE FLORA; INTRAPERITONEAL FAT; INTRAVENOUS GLUCOSE TOLERANCE TEST; MACROPHAGE; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; MORBIDITY; NUTRITIONAL ASSESSMENT; OBESITY; PYROSEQUENCING; REAL TIME POLYMERASE CHAIN REACTION; RNA GENE;

EID: 85007579610     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Carvalho BM and Saad MJ. Influence of gut microbiota on subclinical inflammation and insulin resistance. Mediators Inflamm 2013; 2013: 986734.
2. De Bandt JP, Waligora-Dupriet AJ and Butel MJ. Intestinal microbiota in inflammation and insulin resistance: relevance to humans. Curr Opin Clin Nutr Metab Care 2011; 14: 334-340.
3. Shoelson SE, Lee J and Goldfine AB. Inflam-mation and insulin resistance. J Clin Invest 2006; 116: 1793-1801.
4. Caricilli AM and Saad MJ. The role of gut microbiota on insulin resistance. Nutrients 2013; 5: 829-851.
5. Stachowicz N and Kiersztan A. [The role of gut microbiota in the pathogenesis of obesity and diabetes]. Postepy Hig Med Dosw (Online) 2013; 67: 288-303.
6. Tagliabue A and Elli M. The role of gut microbiota in human obesity: Recent findings and future perspectives. Nutr Metab Cardiovasc Dis 2013; 23: 160-168.
7. Tilg H and Moschen AR. Microbiota and diabetes: an evolving relationship. Gut 2014; 63: 1513-21.
8. Cani PD, Osto M, Geurts L and Everard A. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes 2012; 3: 279-288.
9. Amar J, Burcelin R, Ruidavets JB, Cani PD, Fauvel J, Alessi MC, Chamontin B and Ferrieres J. Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr 2008; 87: 1219-1223.
10. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck A, Lambert DM, Muccioli GG and Delzenne NM. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009; 58: 1091-1103.
11. Verdam FJ, Fuentes S, de Jonge C, Zoetendal EG, Erbil R, Greve JW, Buurman WA, de Vos WM and Rensen SS. Human intestinal microbiota composition is associated with local and systemic inflammation in obesity. Obesity (Silver Spring) 2013; 21: E607-615.
12. Randal Bollinger R, Barbas AS, Bush EL, Lin SS and Parker W. Biofilms in the large bowel suggest an apparent function of the human vermiform appendix. J Theor Biol 2007; 249: 826-831.
13. Rhee KJ, Jasper PJ, Sethupathi P, Shanmugam M, Lanning D and Knight KL. Positive selection of the peripheral B cell repertoire in gut-associated lymphoid tissues. J Exp Med 2005; 201: 55-62.
14. Guinane CM, Tadrous A, Fouhy F, Ryan CA, Dempsey EM, Murphy B, Andrews E, Cotter PD, Stanton C and Ross RP. Microbial composition of human appendices from patients following appendectomy. MBio 2013; 4.
15. Serino M, Fernandez-Real JM, Garcia-Fuentes E, Queipo-Ortuno M, Moreno-Navarrete JM, Sanchez A, Burcelin R and Tinahones F. The gut microbiota profile is associated with insulin action in humans. Acta Diabetol 2013; 50: 753-761.
16. Lohman TG, Roche AF and Martorell R. Anthro-pometric standardization reference manual. Champaign, IL: Human Kinetics Books; 1988.
17. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Pena AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M, Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J, Yatsunenko T, Zaneveld J and Knight R. QIIME allows analysis of high-throughput community sequencing data. Nat Meth 2010; 7: 335-336.
18. De Filippis F, La Storia A, Villani F and Ercolini D. Exploring the sources of bacterial spoilers in beefsteaks by culture-independent high-throughput sequencing. PLoS One 2013; 8: e70222.
19. Cole JR, Wang Q, Cardenas E, Fish J, Chai B, Farris RJ, Kulam-Syed-Mohideen AS, McGarrell DM, Marsh T, Garrity GM and Tiedje JM. The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res 2009; 37: D141-145.
20. Bollinger RR, Barbas AS, Bush EL, Lin SS, Lin SS and Parker W. Biofilms in the normal human large bowel: fact rather than fiction. Gut 2007; 56: 1481-1482.
21. Bollinger RR, Everett ML, Palestrant D, Love SD, Lin SS and Parker W. Human secretory immunoglobulin A may contribute to biofilm formation in the gut. Immunology 2003; 109: 580-587.
22. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N and Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 2007; 104: 13780-13785.
23. Willing B, Halfvarson J, Dicksved J, Rosenquist M, Jarnerot G, Engstrand L, Tysk C and Jansson JK. Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn’s disease. Inflamm Bowel Dis 2009; 15: 653-660.
24. Willing BP, Dicksved J, Halfvarson J, Andersson AF, Lucio M, Zheng Z, Jarnerot G, Tysk C, Jansson JK and Engstrand L. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 2010; 139: 1844-1854, e1841.
25. Nadal I, Donat E, Ribes-Koninckx C, Calabuig M and Sanz Y. Imbalance in the composition of the duodenal microbiota of children with coeliac disease. J Med Microbiol 2007; 56: 1669-1674.
26. Kalliomaki M and Isolauri E. Role of intestinal flora in the development of allergy. Curr Opin Allergy Clin Immunol 2003; 3: 15-20.
27. Kong LC, Tap J, Aron-Wisnewsky J, Pelloux V, Basdevant A, Bouillot JL, Zucker JD, Doré J and Clément K. Gut microbiota after gastric bypass in human obesity: increased richness and associations of bacterial genera with adipose tissue genes. Am J Clin Nutr 2013; 98: 16-24.
28. Amar J, Chabo C, Waget A, Klopp P, Vachoux C, Bermudez-Humaran LG, Smirnova N, Berge M, Sulpice T, Lahtinen S, Ouwehand A, Langella P, Rautonen N, Sansonetti PJ and Burcelin R. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med 2011; 3: 559-572.
29. Cani PD and Delzenne NM. The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des 2009; 15: 1546-1558.
30. Meadows R. Gut Bacteria May Override Genetic Protections against Diabetes. PLoS Biol 2011; 9: e1001215.
31. Tjalsma H, Boleij A, Marchesi JR and Dutilh BE. A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol 2012; 10: 575-582.
32. Derrien M, van Passel MW, van de Bovenkamp JH, Schipper RG, de Vos WM and Dekker J. Mucin-bacterial interactions in the human oral cavity and digestive tract. Gut Microbes 2010; 1: 254-268.
33. Bischoff SC, Barbara G, Buurman W, Ockhuizen T, Schulzke JD, Serino M, Tilg H, Watson A and Wells JM. Intestinal permeability--a new target for disease prevention and therapy. BMC Gastroenterol 2014; 14: 189.
34. Moreno-Indias I, Cardona F, Tinahones FJ and Queipo-Ortuno MI. Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus. Front Microbiol 2014; 5: 190.
35. Burger-van Paassen N, Vincent A, Puiman PJ, van der Sluis M, Bouma J, Boehm G, van Goudoever JB, van Seuningen I and Renes IB. The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: implications for epithelial protection. Biochem J 2009; 420: 211-219.
36. Biddle A, Stewart L, Blanchard J and Leschine S. Untangling the Genetic Basis of Fibrolytic Specialization by Lachnospiraceae and Rumi-nococcaceae in Diverse Gut Communities. Diversity 2013; 5: 627-640.
37. Lewis K, Lutgendorff F, Phan V, Soderholm JD, Sherman PM and McKay DM. Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate. Inflamm Bowel Dis 2010; 16: 1138-1148.
38. Peng L, Li ZR, Green RS, Holzman IR and Lin J. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr 2009; 139: 1619-1625.
39. Udayappan SD, Hartstra AV, Dallinga-Thie GM and Nieuwdorp M. Intestinal microbiota and faecal transplantation as treatment modality for insulin resistance and type 2 diabetes mellitus. Clin Exp Immunol 2014; 177: 24-29.
40. Vrieze A, Van Nood E, Holleman F, Salojarvi J, Kootte RS, Bartelsman JF, Dallinga-Thie GM, Ackermans MT, Serlie MJ, Oozeer R, Derrien M, Druesne A, Van Hylckama Vlieg JE, Bloks VW, Groen AK, Heilig HG, Zoetendal EG, Stroes ES, de Vos WM, Hoekstra JB and Nieuwdorp M. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012; 143: 913-916, e917.
41. Philippe D, Favre L, Foata F, Adolfsson O, Perruisseau-Carrier G, Vidal K, Reuteler G, Dayer-Schneider J, Mueller C and Blum S. Bifidobacterium lactis attenuates onset of inflammation in a murine model of colitis. World J Gastroenterol 2011; 17: 459-469.
42. Williams BL, Hornig M, Parekh T and Lipkin WI. Application of novel PCR-based methods for detection, quantitation, and phylogenetic characterization of Sutterella species in intestinal biopsy samples from children with autism and gastrointestinal disturbances. MBio 2012; 3.
43. Vaziri ND, Wong J, Pahl M, Piceno YM, Yuan J, DeSantis TZ, Ni Z, Nguyen TH and Andersen GL. Chronic kidney disease alters intestinal microbial flora. Kidney Int 2013; 83: 308-315.
44. Geng J, Song Q, Tang X, Liang X, Fan H, Peng H, Guo Q and Zhang Z. Co-occurrence of driver and passenger bacteria in human colorectal cancer. Gut Pathogens 2014; 6: 26-26.